Sphingosine-1-phosphate receptor agonist and antagonist compounds

The present invention is directed to novel, potent, and selective agents, which are agonists or antagonists of the one or more of the individual receptors of the S1P receptor family. The compounds of the invention are useful as therapeutics for treating medical conditions associated with agonism or...

Full description

Saved in:
Bibliographic Details
Main Authors WALLACE GRIER A, GRONGSAARD PINTIPA, GORDON THOMAS D, HAYES MARTIN E, BREINLINGER ERIC C, ANSELL GRAHAM K, CUSACK KEVIN P, HOBSON ADRIAN D, FIX-STENZEL SHANNON R
Format Patent
LanguageEnglish
Published 10.07.2012
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to novel, potent, and selective agents, which are agonists or antagonists of the one or more of the individual receptors of the S1P receptor family. The compounds of the invention are useful as therapeutics for treating medical conditions associated with agonism or antagonism of the individual receptors of the S1P receptor family.
Bibliography:Application Number: US20080075378